search
Company Information
USD
159.62
- (-4.6%)
NYSE:ABBV, ABBVIE INC.
Industry: Drug Manufacturers - General
End of Day: 26 April 2024 GMT-4
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Address

1 North Waukegan Road

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - General

Key Executives

Mr. Richard A. Gonzalez
CEO/Chairman of the Board/Director
Mr. Robert A. Michael
COO/President
Mr. Frederick H. Waddell
Director
Mr. Glenn F. Tilton
Director
Ms. Rebecca B. Roberts
Director
Dr. Robert J. Alpern,M.D.
Director
Mr. Thomas C. Freyman
Director
Mr. Edward J. Rapp
Director
Ms. Roxanne S. Austin
Director
Mr. Brett J. Hart
Director
Mr. Timothy J. Richmond
Executive VP/Other Executive Officer
Dr. Azita Saleki-Gerhardt, PhD
Executive VP/Other Executive Officer
Mr. William H.L. Burnside
Director
Ms. Melody B. Meyer
Director
Mr. Jeffrey Ryan Stewart
Executive VP/Other Executive Officer
Dr. Nicholas Donoghoe
Chief Strategy Officer/Executive VP/Other Executive Officer
Dr. Thomas J. Hudson, M.D.
Chief Scientific Officer/Senior VP, Divisional
Mr. Scott Reents
CFO/Executive VP
Ms. Jennifer L. Davis
Director
Mr. Perry C. Siatis
Executive VP/General Counsel/Secretary
Mr. Kevin K. Buckbee
Chief Accounting Officer/Controller/Senior VP
Dr. Susan Quaggin
Director
Dr. Roopal Thakkar, M.D.
Other Executive Officer/Senior VP, Divisional

Ownership

Institution Holdings

Vanguard Group Inc. ( Junked)
160,380,057 (9.084%)
Vanguard Group Inc
160,398,281 (9.080%)
BlackRock Inc
143,182,709 (8.106%)
State Street Corporation
78,200,866 (4.427%)
Capital Research and Management Company
75,378,838 (4.267%)
Vanguard Investments Australia Ltd
56,438,740 (3.195%)
BlackRock Fund Advisors
53,226,569 (3.013%)
JPMorgan Chase & Co
51,818,311 (2.933%)
Capital Group
47,227,376 (2.674%)
Capital Research & Mgmt Co - Division 3
44,988,183 (2.547%)

Funds Holdings

Vanguard Total Stock Market Index Fund
55,502,917 (3.142%)
Vanguard US Total Market Shares ETF
55,502,917 (3.142%)
Vanguard Institutional 500 Index Trust
43,630,765 (2.470%)
Fidelity 500 Index Fund
20,961,802 (1.187%)
SPDR® S&P 500 ETF Trust
20,723,205 (1.173%)
Capital Group American Mutual Comp
18,855,737 (1.067%)
American Funds American Mutual Fund
18,855,737 (1.067%)
iShares Core S&P 500 ETF
18,368,182 (1.040%)
American Funds Washington Mutual Fund
14,853,619 (0.841%)
Capital Group Wash Mutual Invtrs Comp
14,853,619 (0.841%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices